As of May 01
| -0.14 / -0.95%|
The 9 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 26.48, with a high estimate of 53.77 and a low estimate of 11.35. The median estimate represents a +82.02% increase from the last price of 14.55.
The current consensus among 9 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.